As the deletion polymorphisms of GSTT1 and GSTM1 are associated with increased risk for HNSCC and interact multiplicatively with tobacco exposure [58], chemoprevention with isothiocyanates may be most beneficial in double null individuals. This evidence concerns the gene GSTM1 and head and neck squamous cell carcinoma.